236 related articles for article (PubMed ID: 16585556)
21. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
[TBL] [Abstract][Full Text] [Related]
22. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation.
Fortenbery NR; Paraiso KH; Taniguchi M; Brooks C; Ibrahim L; Kerr WG
J Immunol; 2010 May; 184(9):5065-74. PubMed ID: 20363967
[TBL] [Abstract][Full Text] [Related]
23. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.
Velikovsky CA; Deng L; Chlewicki LK; Fernández MM; Kumar V; Mariuzza RA
Immunity; 2007 Oct; 27(4):572-84. PubMed ID: 17950006
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
Sinha SK; Gao N; Guo Y; Yuan D
J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48.
Kubin MZ; Parshley DL; Din W; Waugh JY; Davis-Smith T; Smith CA; Macduff BM; Armitage RJ; Chin W; Cassiano L; Borges L; Petersen M; Trinchieri G; Goodwin RG
Eur J Immunol; 1999 Nov; 29(11):3466-77. PubMed ID: 10556801
[TBL] [Abstract][Full Text] [Related]
26. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
Lee KM; McNerney ME; Stepp SE; Mathew PA; Schatzle JD; Bennett M; Kumar V
J Exp Med; 2004 May; 199(9):1245-54. PubMed ID: 15123744
[TBL] [Abstract][Full Text] [Related]
27. 2B4 (CD244) is expressed and functional on human eosinophils.
Munitz A; Bachelet I; Fraenkel S; Katz G; Mandelboim O; Simon HU; Moretta L; Colonna M; Levi-Schaffer F
J Immunol; 2005 Jan; 174(1):110-8. PubMed ID: 15611233
[TBL] [Abstract][Full Text] [Related]
28. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
[TBL] [Abstract][Full Text] [Related]
29. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.
Stark S; Watzl C
Int Immunol; 2006 Feb; 18(2):241-7. PubMed ID: 16410313
[TBL] [Abstract][Full Text] [Related]
30. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
Vaidya SV; Mathew PA
Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
[TBL] [Abstract][Full Text] [Related]
31. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.
Johnson LA; Vaidya SV; Goldfarb RH; Mathew PA
Anticancer Res; 2003; 23(5A):3651-5. PubMed ID: 14666660
[TBL] [Abstract][Full Text] [Related]
32. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
[TBL] [Abstract][Full Text] [Related]
33. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
Vaidya SV; Stepp SE; McNerney ME; Lee JK; Bennett M; Lee KM; Stewart CL; Kumar V; Mathew PA
J Immunol; 2005 Jan; 174(2):800-7. PubMed ID: 15634901
[TBL] [Abstract][Full Text] [Related]
34. 2B4 inhibits NK-cell fratricide.
Taniguchi RT; Guzior D; Kumar V
Blood; 2007 Sep; 110(6):2020-3. PubMed ID: 17537992
[TBL] [Abstract][Full Text] [Related]
35. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
[TBL] [Abstract][Full Text] [Related]
37. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Schweer K; Kailayangiri S; Campana D; Juergens H; Pule M; Rossig C
Clin Cancer Res; 2009 Aug; 15(15):4857-66. PubMed ID: 19638467
[TBL] [Abstract][Full Text] [Related]
38. Identification of the 2B4 molecule as a counter-receptor for CD48.
Latchman Y; McKay PF; Reiser H
J Immunol; 1998 Dec; 161(11):5809-12. PubMed ID: 9834056
[TBL] [Abstract][Full Text] [Related]
39. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.
McNerney ME; Lee KM; Kumar V
Mol Immunol; 2005 Feb; 42(4):489-94. PubMed ID: 15607804
[TBL] [Abstract][Full Text] [Related]
40. NK cell regulation by SLAM family receptors and SAP-related adapters.
Veillette A
Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]